One of the most advanced weight loss drugs, Mounjaro, is to be sold in India by US pharma major Eli Lilly.
Mounjaro contains an active substance called tirzepatide.
It mimics the action of certain gut hormones to improve secretion of the blood-sugar regulating insulin, inhibits secretion of glucagon.
It mimics the two hormones, glucagon-like peptide-1 (GLP-1) and the glucose-dependent insulinotropic polypeptide (GIP), to lower the blood sugar and promote weight loss.
Tirzepatide is primarily intended for the people with Type 2 diabetes who cannot control their blood sugar despite following a proper diet and taking some other medications.